← back to search

Thomas M. Ashhurst

The University of Sydney · AU
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Single-cell and spatial transcriptomics, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, and Cell Image Analysis Techniques.
h-index
24
citations
1,951
works
79
NIH funding
primary concept
email

Recent publications

Faecal microbial transfer and complex carbohydrates mediate protection against COPD
Gut 2024cited by 58position: middledoi
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
Nature Communications 2024cited by 20position: middledoi
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
Nature Immunology 2023cited by 40position: middledoi
The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
Journal of Neuroinflammation 2022cited by 80position: middledoi
A high‐dimensional cytometry atlas of peripheral blood over the human life span
Immunology and Cell Biology 2022cited by 46position: middledoi
Integration, exploration, and analysis of high‐dimensional single‐cell cytometry data using Spectre
Cytometry Part A 2021cited by 188position: firstdoi
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
Cell Reports Medicine 2021cited by 176position: middledoi
An updated guide for the perplexed: cytometry in the high-dimensional era
Nature Immunology 2021cited by 93position: middledoi
Making the most of high‐dimensional cytometry data
Immunology and Cell Biology 2021cited by 30position: middledoi
Evaluating spectral cytometry for immune profiling in viral disease
Cytometry Part A 2020cited by 61position: middledoi
Analysis of the Murine Bone Marrow Hematopoietic System Using Mass and Flow Cytometry
Methods in molecular biology 2019cited by 35position: firstdoi
Varicella zoster virus productively infects human natural killer cells and manipulates phenotype
PLoS Pathogens 2018cited by 57position: middledoi
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Science Translational Medicine 2014cited by 371position: middledoi
Defective Inflammatory Monocyte Development in IRF8-Deficient Mice Abrogates Migration to the West Nile Virus-Infected Brain
Journal of Innate Immunity 2014cited by 37position: middledoi
Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages
Journal of Neuroinflammation 2012cited by 95position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicholas J. C. King · Institute for Biomedicine5 papers (2012–2021)Adrian L. Smith · Calderdale and Huddersfield NHS Foundation Trust3 papers (2019–2021)Iain L. Campbell · The University of Sydney3 papers (2012–2022)Felix Marsh‐Wakefield · The University of Sydney2 papers (2021–2021)Céline Deffrasnes · Australian Regenerative Medicine Institute2 papers (2012–2014)Meghann Teague Getts · Northwestern University2 papers (2012–2014)Rachael Terry · Children's Cancer Institute Australia2 papers (2012–2014)Markus J. Hofer · The University of Sydney2 papers (2012–2022)Daniel R. Getts · Genocea (United States)2 papers (2012–2014)Helen M. McGuire · Charles Sturt University1 papers (2021–2021)Darren Anthony Cox · The University of Sydney1 papers (2019–2019)Shuo Li · Sun Yat-sen University Cancer Center1 papers (2022–2022)Oleg Butovsky · Brigham and Women's Hospital1 papers (2022–2022)Alanna G. Spiteri · The University of Sydney1 papers (2021–2021)Givanna Putri · Walter and Eliza Hall Institute of Medical Research1 papers (2021–2021)Paul V. Licciardi · London School of Hygiene & Tropical Medicine1 papers (2022–2022)Boris Guennewig · The University of Sydney1 papers (2022–2022)Phillip K. West · The University of Sydney1 papers (2022–2022) · 1 papers (2022–2022)Jeremy Anderson · Imperial College Healthcare NHS Trust1 papers (2022–2022)